Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-4 Registration of securities issued in business combination transactions
- 5.1 EX-5.1
- 5.2 EX-5.2
- 5.3 EX-5.3
- 5.4 EX-5.4
- 5.5 EX-5.5
- 5.6 EX-5.6
- 5.7 EX-5.7
- 5.8 EX-5.8
- 5.9 EX-5.9
- 12.1 EX-12.1
- 12.2 EX-12.2
- 23.1 EX-23.1
- 23.2 EX-23.2
- 23.3 EX-23.3
- 23.4 EX-23.4
- 23.5 EX-23.5
- 23.6 EX-23.6
- 25.1 EX-25.1
- 99.1 EX-99.1
- 99.2 EX-99.2
- 99.3 EX-99.3
- 99.4 EX-99.4
Ameditech similar filings
- 2 Jul 13 Registration of securities issued in business combination transactions (amended)
- 8 Apr 13 Registration of securities issued in business combination transactions
- 8 Dec 10 Registration of securities issued in business combination transactions (amended)
- 26 Nov 10 Registration of securities issued in business combination transactions
- 19 Apr 10 Registration of securities issued in business combination transactions (amended)
- 26 Mar 10 Registration of securities issued in business combination transactions (amended)
- 12 Feb 10 Registration of securities issued in business combination transactions
Filing view
External links
Exhibit 23.6
CONSENT OF INDEPENDENT ACCOUNTANTS
We hereby consent to the incorporation by reference in the Registration Statement on Form S-4 of Alere Inc. (formerly, “Inverness Medical Innovations, Inc.”) of our report dated May 24, 2010 relating to the financial statements of Standard Diagnostics, Inc., which appears in the Current Report on Form 8-K of Alere Inc. dated May 28, 2010. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ Samil PricewaterhouseCoopers
Seoul, Korea
Seoul, Korea
November 24, 2010